Vladimir Ljubicic

11PUBLICATIONS
10CO-AUTHORS
Gene and molecular therapyMotor controlNeurology and neuromuscular diseasesMetabolic medicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 04, 2026
Direct AMPK Activation Confers Mutation-Independent Therapeutic Benefit in Duchenne Muscular Dystrophy.

Sean Y Ng, Andrew I Mikhail, Stephanie R Mattina

|Feb 04, 2025
Skeletal Muscle Mitochondrial and Autophagic Dysregulation Are Modifiable in Spinal Muscular Atrophy.

Andrew I Mikhail, Sean Y Ng, Donald Xhuti

|Nov 29, 2023
CARM1 drives mitophagy and autophagy flux during fasting-induced skeletal muscle atrophy.

Derek W Stouth, Tiffany L vanLieshout, Andrew I Mikhail

|Jul 26, 2023
Impact of short-term, pharmacological CARM1 inhibition on skeletal muscle mass, function, and atrophy in mice.

Erin K Webb, Sean Y Ng, Andrew I Mikhail

|Apr 05, 2023
Acute, next-generation AMPK activation initiates a disease-resistant gene expression program in dystrophic skeletal muscle.

Sean Y Ng, Andrew I Mikhail, Stephanie R Mattina

Pageof 2